Bloodwork question about modafinil. Baseline, two years in, and the numbers moved in a direction I did not expect.

Most of the popular protocols are borrowed from clinical populations and applied to healthy people without comment.

Baseline first. Without a baseline the after picture is decoration.

The comparison group matters more than the compound when the outcome is something as fuzzy as focus.

Two weeks is not enough time to attribute anything to a compound unless the effect is dramatic.

What would change your mind about this?